You are here

Drug Shortage Report Recommends a Rating System for Manufacturers

Grading manufacturers would give high-quality, reliable makers a boost, says federal panel

An inter-agency task force on drug shortages has recommended developing a rating system for drug manufacturers that would grade them on their “mature quality management,” which includes their reliability. Currently, the report says, manufacturers aim to comply with the FDA’s Current Good Manufacturing Practices and have no incentive to do better.

The report, which was released by the FDA earlier this week, identifies various market failures and pricing as the root causes of drug shortages. A rating system would make the market work better by giving buyers more information and “provide [manfactuers] committed to quality management maturity with a competitive advantage,” says the report, titled Drug Shortages: Root Causes and Potential Solutions.

Source: FDA, October 29

 

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks